The Latest in Leukemia, Myelodysplasia, Transplantation

High response, survival rates with ponatinib/hCVAD in Ph-positive ALL

January 8, 2020

Leukemia, Myelodysplasia, Transplantation

CAR T cells produce complete responses in T-cell malignancies

January 7, 2020

CAR T-cell therapy advances in CLL

December 26, 2019

Zanubrutinib achieved high response rate in del(17p) CLL cohort

December 16, 2019

Leukemia, Myelodysplasia, Transplantation

Blinatumomab instead of chemo in young patients with relapsed ALL

December 13, 2019

Leukemia, Myelodysplasia, Transplantation

Oral azacitidine: First maintenance therapy for AML

December 13, 2019

Leukemia, Myelodysplasia, Transplantation

Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLL

December 10, 2019

Kidney function in African American AML patients not linked to reduced survival compared with whites

December 7, 2019

Leukemia, Myelodysplasia, Transplantation

FDA approves acalabrutinib for CLL, SLL treatment

November 21, 2019

Leukemia, Myelodysplasia, Transplantation

Will TP53-mutated AML respond to immunotherapy?

November 18, 2019

Researchers seek a way to predict cognitive deficits in children treated for ALL

November 15, 2019

Gene signature may help guide initial CLL treatment choice

November 14, 2019

Caspofungin bests fluconazole for antifungal prophylaxis in young AML patients

November 5, 2019

Consider renal function in TLS risk assessment of venetoclax-treated CLL

October 29, 2019

Hematopoietic cell transplant offers realistic cure in secondary AML

October 23, 2019

Leukemia, Myelodysplasia, Transplantation